相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
Milton Packer
EUROPEAN HEART JOURNAL (2020)
Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: theVIP-HFstudy
Dirk J. van Veldhuisen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause A PARADIGM-HF Analysis
Luis E. Rohde et al.
JACC-HEART FAILURE (2020)
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF
Sean D. Pokorney et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
Muthiah Vaduganathan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction
Niyada Naksuk et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)
Declining Risk of Sudden Death in Heart Failure
Li Shen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Finnian R. Mc Causland et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: Apooled analysis of 4 randomized controlled trials
Daniel J. Friedman et al.
AMERICAN HEART JOURNAL (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
Ramin Shadman et al.
HEART RHYTHM (2015)
Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized Trials
Patrick H. Pun et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Association Between Bilirubin and Mode of Death in Severe Systolic Heart Failure
Audrey H. Wu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
Michael R. Zile et al.
CIRCULATION (2010)
Logistic regression and CART in the analysis of multimarker studies
Reinhold Muller et al.
CLINICA CHIMICA ACTA (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
Leslie A. Saxon et al.
CIRCULATION (2006)
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation
JP Singh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
SD Anker et al.
CIRCULATION (2003)
分享论文
